Circassia Pharmaceuticals Plc Notification of Major Interest in Shares (5772C)

TIDMCIR

RNS Number : 5772C

Circassia Pharmaceuticals Plc

18 April 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                                    Circassia Pharmaceuticals 
  the underlying issuer                                                                                plc 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ----------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------------------------------------------ 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------------------------------------------ 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------------------------------------------ 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------------------------------ 
 Other (please                                              Passive change: threshold passed due         X 
  specify):                                                 to an increase in the total number 
                                                            of voting rights in the company 
---------------------------------------------------------  ------------------------------------------- 
 3. Full name of person(s)                                                          OppenheimerFunds, Inc. 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  --------------------------------------------- 
 5. Date of the transaction                                                                  12 April 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------------------------- 
 6. Date on which issuer                                                                     13 April 2017 
  notified: 
-----------------------------------------------------------  --------------------------------------------- 
 7. Threshold(s) that is/are                                                      10% (decreased to 9.79%) 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  --------------------------------------------- 
 
 
 
 8. Notified details: 
  Investor Relations Contact: 
  Circassia Pharmaceuticals plc 
  Northbrook House 
  Robert Robinson Avenue 
  The Oxford Science Park 
  Oxford OX4 4GA 
  United Kingdom 
  Tel [phone] 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                   Resulting situation after the triggering 
  of             to the triggering                    transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  -----------------------------------  ------------------------------------------------------------------ 
                Number            Number             Number          Number of voting         % of voting 
                 of                of                 of shares       rights                   rights (x) 
                 Shares            Voting 
                                   Rights 
-------------  ----------------  -----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     (xi)        (xii) 
-------------      ------------    -------------    --------------  ---------  ------------  ------------  ----------- 
 GB00BJVD3B28   32,540,657        32,540,657                                    32,540,657                  9.79% 
               ----------------  -----------------  --------------  ---------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration      Exercise/                          Number of voting           % of voting 
 financial           date            Conversion                         rights that                rights 
 instrument          (xiii)          Period (xiv)                       may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
-----------------  --------------  ---------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise        Expiration       Exercise/         Number of voting           % of voting 
 financial         price          date             Conversion         rights instrument          rights (xix, 
 instrument                       (xvii)           period             refers to                  xx) 
                                                   (xviii) 
---------------  --------------  ---------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  --------------  ---------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 32,540,657                                            9.79% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
----------------------------------------------------------------------------------------------------- 
 
                                            OppenheimerFunds, Inc. ("OFI") is a registered investment 
                                              advisor with the U.S. SEC. Its ultimate parent company, 
                                               Massachusetts Mutual Life Insurance Company, qualifies 
                                                 for disaggregation under FSA regulations. The shares 
                                                of the issuer are held by investment accounts managed 
                                             by OFI and its wholly owned subsidiary, OFI Global Asset 
                                                                           Management, Inc. ("OFIG"). 
 
 Proxy Voting: 
----------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  -------------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  -------------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  -------------------------------------- 
 
 
  13. Additional information:                                              The percentage of holdings 
                                                                          noted above is based on the 
                                                                       updated total number of voting 
                                                                             rights in the company to 
                                                                         be 332,244,588, as disclosed 
                                                                           by the company on 12 April 

                                                                  2017 (Completion of the Transaction 
                                                                             and admission to trading 
                                                                       on the London Stock Exchange), 
                                                                        which has caused OFI to cross 
                                                                             below the 10% threshold. 
-------------------------------------------------------------  -------------------------------------- 
 14. Contact name:                                                                       Julien Cotta 
-------------------------------------------------------------  -------------------------------------- 
 15. Contact telephone number:                                                           01865 405560 
-------------------------------------------------------------  -------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLIPMLTMBBBMFR

(END) Dow Jones Newswires

April 18, 2017 05:20 ET (09:20 GMT)